Cargando…

Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin’s lymphoma with considerable heterogeneity and different clinical prognosis. However, plasma metabomics used to forecast occurrence and prognosis of DLBCL are rarely addressed. METHOD: A total of 65 volunteers including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fei, Fei, Zheng, Meihong, Xu, Zhenzhen, Sun, Runbin, Chen, Xin, Cao, Bei, Li, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207198/ https://www.ncbi.nlm.nih.gov/pubmed/35734601 http://dx.doi.org/10.3389/fonc.2022.894891

Ejemplares similares

Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
por: Larousserie, Frédérique, et al.
Publicado: (2019)

Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma
por: Zhang, Qikai, et al.
Publicado: (2022)

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
por: Zhang, Jun, et al.
Publicado: (2018)

Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma
por: Zhao, Xin-yu, et al.
Publicado: (2022)

The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms
por: Yazdanparast, Somayeh, et al.
Publicado: (2022)

Circulating tumor DNA mutation profile is associated with the prognosis and treatment response of Chinese patients with newly diagnosed diffuse large B-cell lymphoma
por: Guan, Tao, et al.
Publicado: (2022)

Secondary Diffuse Large B-cell Lymphoma Mimicking Meningioma
por: Garcia-Grimshaw, Miguel, et al.
Publicado: (2019)

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

Bilateral Primary testicular diffuse large B-CELL lymphoma
por: Trama, Francesco, et al.
Publicado: (2021)

Serum Abnormal Metabolites for Evaluating Therapeutic Response and Prognosis of Patients With Multiple Myeloma
por: Wei, Yujun, et al.
Publicado: (2022)

Composite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case Report
por: Mohammad, Farhan, et al.
Publicado: (2017)

Genetic Polymorphisms in CD35 Gene Contribute to the Susceptibility and Prognosis of Hepatocellular Carcinoma
por: Luo, Limei, et al.
Publicado: (2021)

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
por: Cascione, Luciano, et al.
Publicado: (2020)

The findings on the CEUS of diffuse large B cell lymphoma in abdomen: A case report and literature review
por: Zhang, Yu-Qing, et al.
Publicado: (2023)

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Li, Peifeng, et al.
Publicado: (2021)

Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points
por: Lokeshwar, Soum D., et al.
Publicado: (2021)

Chronic Heel Pain Found to Be Diffuse Large B-cell Lymphoma of the Calcaneus
por: Horner, Kevin J, et al.
Publicado: (2022)

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
por: Nair, Reena, et al.
Publicado: (2023)

miRNome expression analysis in canine diffuse large B-cell lymphoma
por: Elshafie, Nelly O., et al.
Publicado: (2023)

New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
por: Arcari, Annalisa, et al.
Publicado: (2023)

Hematolymphoid tumor of prostate: Diffuse large B cell lymphoma case report
por: Ochirjav, Enkhee, et al.
Publicado: (2023)

Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry
por: Nair, Reena, et al.
Publicado: (2022)

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
por: Ghandili, Susanne, et al.
Publicado: (2023)

Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers
por: Sheng, Lingshuang, et al.
Publicado: (2022)

Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies
por: Decruyenaere, Philippe, et al.
Publicado: (2023)

Flow Cytometry-Assessed PD1/PDL1 Status in Tumor-Infiltrating Lymphocytes: A Link With the Prognosis of Diffuse Large B-Cell Lymphoma
por: Chen, Zihang, et al.
Publicado: (2021)

Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non‐small cell lung cancer
por: Sun, Runbin, et al.
Publicado: (2023)

The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Prognostic and clinicopathological role of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: A meta-analysis
por: Cao, Dan, et al.
Publicado: (2023)

Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients
por: Fei, Yue, et al.
Publicado: (2020)

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
por: Miao, Yi, et al.
Publicado: (2019)

Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma
por: Roh, Jin, et al.
Publicado: (2020)

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma
por: Wei, Xiaolei, et al.
Publicado: (2021)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
por: Lee, Boram, et al.
Publicado: (2021)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
por: Gu, Qianhui, et al.
Publicado: (2021)

Primary diffuse large B-Cell lymphoma of the female urethra: A case report
por: Boughaleb, Abdelmounim, et al.
Publicado: (2023)

Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
por: Luan, Chunyan, et al.
Publicado: (2020)

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Yin, Chengliang, et al.
Publicado: (2020)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma
por: Wang, Zanzan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gq048bb6fhaimvnik8go6ce1bu